Helius Medical Technologies Announces Reverse Stock Split

Core Viewpoint - Helius Medical Technologies, Inc. announced a 1-for-15 reverse stock split of its Class A common stock, effective May 1, 2025, to comply with Nasdaq listing requirements [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will convert every 15 shares of common stock into one share, maintaining the par value at $0.001 and the authorized number of shares at 150 million [2][4]. - Following the reverse split, the number of outstanding shares will decrease from approximately 7.9 million to about 0.5 million [4]. - The reverse stock split will proportionately reduce the number of shares issuable upon conversion of stock options and warrants, increasing their conversion and exercise prices accordingly [3]. Group 2: Trading Information - The common stock will continue to trade on The Nasdaq Capital Market under the symbol "HSDT" with a new CUSIP number of 42328V 884 after the split [4]. - Any fractional shares resulting from the reverse split will be rounded down to the nearest whole share, with stockholders receiving cash for the market value of the fractional share [3]. Group 3: Company Overview - Helius Medical Technologies focuses on neurologic deficits through a novel therapeutic neuromodulation approach, with its first commercial product being the Portable Neuromodulation Stimulator (PoNS) [6].